HEALTHY EXTRACTS INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2 USD | -10.31% |
|
-.--% | -72.22% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 3.721 | 18.35 | 15.87 | 13.81 | 21.27 |
| Enterprise Value (EV) 1 | 6.227 | 18.47 | 15.99 | 14.33 | 22.38 |
| P/E ratio | 5.35 x | -5.53 x | -7.53 x | -13.9 x | -8.49 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 4.97 x | 14.4 x | 10.8 x | 6.13 x | 8.56 x |
| EV / Revenue | 8.32 x | 14.5 x | 10.9 x | 6.37 x | 9 x |
| EV / EBITDA | -6.69 x | -9.22 x | -8.7 x | -15.7 x | -9.98 x |
| EV / FCF | -1,286,833 x | -8,328,014 x | -82,230,188 x | 324,000,701 x | 47,638,790 x |
| FCF Yield | -0% | -0% | -0% | 0% | 0% |
| Price to Book | -4.28 x | 6.49 x | 6.42 x | 7.35 x | 22.3 x |
| Nbr of stocks (in thousands) | 1,013 | 2,548 | 2,820 | 2,876 | 2,954 |
| Reference price 2 | 3.672 | 7.200 | 5.628 | 4.800 | 7.200 |
| Announcement Date | 8/10/20 | 2/19/21 | 4/1/22 | 3/31/23 | 4/1/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.0671 | 0.7484 | 1.277 | 1.466 | 2.251 | 2.486 |
| EBITDA 1 | -0.4992 | -0.9313 | -2.003 | -1.837 | -0.9107 | -2.242 |
| EBIT 1 | -0.5075 | -0.9399 | -2.012 | -1.842 | -0.9116 | -2.244 |
| Operating Margin | -755.96% | -125.59% | -157.6% | -125.69% | -40.49% | -90.26% |
| Earnings before Tax (EBT) 1 | -3.323 | 0.6328 | -2.576 | -1.987 | -0.9831 | -2.473 |
| Net income 1 | -3.33 | 0.6328 | -2.576 | -1.987 | -0.9831 | -2.473 |
| Net margin | -4,959.73% | 84.55% | -201.82% | -135.57% | -43.67% | -99.48% |
| EPS 2 | -145.4 | 0.6865 | -1.303 | -0.7470 | -0.3444 | -0.8482 |
| Free Cash Flow | - | -4.839 | -2.217 | -0.1945 | 0.0442 | 0.4697 |
| FCF margin | - | -646.6% | -173.69% | -13.27% | 1.97% | 18.9% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/10/20 | 8/10/20 | 2/19/21 | 4/1/22 | 3/31/23 | 4/1/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.78 | 2.51 | 0.12 | 0.12 | 0.53 | 1.11 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -1.559 x | -2.69 x | -0.0591 x | -0.0656 x | -0.5796 x | -0.4943 x |
| Free Cash Flow | - | -4.84 | -2.22 | -0.19 | 0.04 | 0.47 |
| ROE (net income / shareholders' equity) | - | -28.6% | -259% | -74.6% | -45.2% | -175% |
| ROA (Net income/ Total Assets) | - | -33.2% | -38.3% | -37.5% | -19.6% | -51.8% |
| Assets 1 | - | -1.904 | 6.725 | 5.302 | 5.013 | 4.775 |
| Book Value Per Share 2 | -156.0 | -0.8600 | 1.110 | 0.8800 | 0.6500 | 0.3200 |
| Cash Flow per Share 2 | 0.0200 | 0.1300 | 0.0200 | 0.0800 | 0.0200 | 0.0100 |
| Capex | - | 0.02 | - | - | 0.01 | - |
| Capex / Sales | - | 3.07% | - | - | 0.35% | - |
| Announcement Date | 8/10/20 | 8/10/20 | 2/19/21 | 4/1/22 | 3/31/23 | 4/1/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -72.22% | 5.93M | |
| +40.09% | 6.3B | |
| -16.34% | 4.53B | |
| -7.11% | 3.29B | |
| +5.14% | 3.2B | |
| -0.18% | 2.63B | |
| +47.93% | 1.97B | |
| -7.15% | 1.74B | |
| +0.67% | 1.69B | |
| -8.73% | 1.64B |
- Stock Market
- Equities
- HYEX Stock
- Financials Healthy Extracts Inc.